Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinical Rheumatology|September 1, 1996
Calciphylaxis: a condition mimicking necrotizing vasculitisM Melikoglu, S Apaydin, V Hamuryudan, et al.
Annals of Internal Medicine|March 14, 1998
Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trialV Hamuryudan, C Mat, S Saip, et al.
Arthritis and Rheumatism|November 17, 2001
A double-blind trial of colchicine in Behçet's syndromeS Yurdakul, C Mat, Y Tüzün, et al.
Clinical and Experimental Rheumatology|October 1, 1987
Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritisH Yazici, C Mat, S Deniz, et al.
Arthritis and Rheumatism|April 1, 1997
Azathioprine in Behcet's syndrome: effects on long-term prognosisV Hamuryudan, Y Ozyazgan, N Hizli, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's Syndrome Research CentreH Yazici, I Fresko, V Hamuryudan, et al.
The Journal of Rheumatology|September 1, 1994
The prevalence of Sjögren's syndrome in Behçet's syndromeI Günaydin, C Ustündağ, G Kaner, et al.
Rheumatology (Oxford, England)|November 3, 2005
A double-blind trial of depot corticosteroids in Behçet's syndromeC Mat, S Yurdakul, S Uysal, et al.
The Journal of Rheumatology|May 6, 1999
Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsetsE Ekşioglu-Demiralp, A Kibaroglu, H Direskeneli, et al.
Tissue Antigens|February 1, 1981
Behçet's disease: lack of correlation of clinical manifestations with HLA antigensA U Müftüoğlu, H Yazici, S Yurdakul, et al.
Pageof 10